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Background. Little is known about the course of poststroke fatigue. Objectives. To describe the course of poststroke fatigue in
relation to the patient’s level of physical functioning, depressive symptoms, and self-reported history of prestroke fatigue. Methods.
A longitudinal study using structured face-to-face interviews, questionnaires, and patients’ medical records. Data were collected
from 95 patients in Norway with ﬁrst-ever stroke. Fatigue was measured with the Fatigue Severity Scale 7 item version and assessed
for change between the acute phase, six, 12, and 18 months after stroke using 2-way ANOVA repeated-measures analyses. Results.
The patients’ level of fatigue did not change over time. However, those who reported prestroke fatigue showed a relatively high
level of fatigue over time in the poststroke period, while patients with no history of pre-stroke fatigue showed a stable course of
relatively low fatigue over time. Conclusion. Studies on poststroke fatigue should control for the patient’s pre-stroke fatigue level.
1.Introduction
Fatigue is one of the most common complaints after stroke
[1, 2]. Despite this, little is known about the development
of poststroke fatigue, its development over time and how
this development is related to other clinical factors. A few
longitudinal studies have been conducted, but to our know-
ledge, no longitudinal studies have considered that patients
with poststroke fatigue may have experienced fatigue for
a long time before stroke. In fact, epidemiological studies
report that approximately 20–25% of the general population
experiencecurrentfatigue[3,4].Arelationshipbetweenpre-
stroke fatigue and poststroke fatigue has previously been
reported in a cross-sectional study [5] 15 months after stroke
(mean time after stroke) and in a study of stroke patients
in the acute phase [6]. Thus, prestroke fatigue may confound
the clinical covariates associated with poststroke fatigue
reported in previous studies.
Fatigue can be deﬁned as a sense of exhaustion, lack of
perceived energy, or tiredness [7, 8] distinct from sadness or
weakness [7]. Because of the subjective character of fatigue
andthefactthatnoobjectivesignsoftheconditionhavebeen
identiﬁed, self-report is seen as the most valid way to assess
fatigue [9]. Although fatigue is understood as multidimen-
sional with mental, physical, and motivational aspects [8],
the Fatigue Severity Scale (FSS) is a one-dimensional self-
report measure frequently used to assess fatigue in stroke
populations [9].
In a previous published review of poststroke studies [9],
poststroke fatigue was more common among women [10–
12] and in those reporting a history of fatigue prior to
their stroke [5]. Furthermore, poststroke fatigue was related
to higher levels of depression [5, 13–19], sleep disturbance
[5, 17], and dependency [5, 17, 18]. Some researchers have
also observed a signiﬁcant relationship between a patient’s2 Stroke Research and Treatment
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Figure 1: Time course for fatigue among men (n = 56) and women
(n = 39). Adjusted for level of physical functioning, depressive
symptoms, and prestroke fatigue. Bars are lower and upper 95% CI.
fatigue and neurological impairment [5, 18] while others
have not [16, 17].
In a cross-sectional sample of stroke patients in the acute
phase [6], we previously reported a higher proportion of
cases of severe fatigue among women than among men,
and that poststroke fatigue was related to current depressive
symptoms, lower physical functioning in patients, and self-
report history of prestroke fatigue. This paper reports on the
ﬁndings from an 18 month follow-up of the participants of
the cross-sectional study.
Based on previous ﬁndings, the aims of this study were
to (1) describe the course of fatigue from the acute phase
through six, 12, and 18 months in patients with ﬁrst-ever
stroke and (2) explore the time course related to the patient’s
level of physical functioning, depressive symptoms, and re-
trospective self-report of prestroke fatigue.
2. Methods
2.1. Participants and Procedures. Participants were recruited
to a longitudinal poststroke fatigue study between March
2007 and September 2008 at a hospital in the southeastern
region of Norway, and between September 2007 and June
2008 at a university hospital in Oslo. Upon admission to
the hospital, patients with a clinical diagnosis of ﬁrst-ever
stroke were recruited for the study. Data were collected from
medical records and in standardized interviews by three
trained interviewers using validated questionnaires. When
the patients were recruited to the study, they were inform-
ed that one of their signiﬁcant others could be present
during the interviews, but this occurred in very few cases.
To ease the study participant burden in the acute phase,
the interviews were conducted at two diﬀerent times within
48 hours. Data on health-related quality of life (HRQoL)
and fatigue were collected during the ﬁrst interview, while
data on sleep quality and depression were obtained during
the second interview. At six, 12, and 18 months, data were
collected by means of the same questionnaires used in the
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Figure 2: Time course for fatigue by patients with low depression
scores (n = 68) versus those with medium-high depression scores
(n = 26). Adjusted for level of physical functioning and prestroke
fatigue. Bars are lower and upper 95% CI.
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Figure 3: Time course for fatigue by patients with low physical
functioning(PF)(n = 61)versusthosewithhighPF(n = 33).Ad-
justed for level of depression and prestroke fatigue. Bars are lower
and upper 95% CI.
acute phase. Interviews in the acute phase were usually per-
formed in the hospital, either in the patients room if they
were alone or in a secluded room onsite. At the follow-
up times, most participants were visited in their homes by
one of the interviewers. For those who were working or tra-
velling abroad at the time of the follow-up data collection,
the questionnaires were sent by mail and returned in a
sealed envelope. Inclusion criteria for the study were that
the patients had a ﬁrst-ever clinical presentation of strokeStroke Research and Treatment 3
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Figure 4:Timecourseforfatiguebypatientswithnoprestrokefati-
gue (n = 69) and those with prestroke fatigue (n = 26). Adjusted
for level of physical functioning and depressive symptoms. Bars are
lower and upper 95% CI.
deﬁned according to the ICD-10 (I 60, 61, 62, 63, and 64)
[20] were 18 years or older and had adequate cognitive
functioning to allow participation. Patients who were fully
conscious or were somnolent but could be awakened to full
consciousness (equivalent to a score of 4 or 6 on item
number 1 in the Scandinavian Stroke Scale [SSS]) [21]a n d
oriented for time, place, and person (equivalent to a score
of 4 on item number 6 in the SSS) were eligible. At one
hospital, those who did not meet the criteria for cognitive
functioning were further assessed with the MiniMental State
Examination (MMSE). Those with an MMSE score ≤10 and
those with an MMSE score between 11 and 23, but who were
found cognitively incompetent by a physician or a nurse,
were excluded. At the second hospital, patients who did not
meet the SSS criteria were clinically assessed by the stroke
team. Patients who were found to be cognitively impaired
were excluded from participation.
In addition, patients who were assessed by the recruiting
nurses to be unable to communicate (participate in a mean-
ingful conversation with an interviewer or point to the res-
ponse alternatives on questionnaires) were excluded. Of the
193 patients with a diagnosis of ﬁrst-ever stroke, 14 were
excluded because of poor cognitive functioning, 26 were
excluded because of stroke-related diﬃculty in communi-
cating, and one was excluded because of an inability to
understand Norwegian. Of the 152 patients eligible to parti-
cipate, 125 patients consented (82%) and 6 died or were
transferred to hospitals in other regions before collection
of the ﬁrst set of data, resulting in the ﬁnal sample of 119
patients. Data from 4 of the 119 patients were collected later
than15daysafteradmissionandwereexcludedfromanalysis
for acute phase ﬁndings. The study sample from the acute
phase is described in detail in a previous report [6]. During
the follow-up visits, 8 participants were excluded due to
death, 3 had other serious illnesses, and 4 did not wish to
participate in further data collection. Five more participants
were excluded for other reasons: three did not respond when
they were contacted by the research team at the follow-up
times and two were on holiday at the six-month follow-up.
Thus, 95 participants had valid responses on the FSS and
responded to all the items in the questionnaires at all four
time points; these 95 were included in this analysis.
2.2. Measurements
2.2.1. Fatigue. The 9-item FSS is the most commonly used
instrument to measure fatigue in stroke patients [9, 13,
22, 23]. It has shown high validity and reliability [24–
26]. A recent published review of fatigue measures in
people with chronic illness reported that the FSS had the
best psychometric properties [27]. Participants are asked to
respond to the statements about their fatigue on a 7-point
Likert scale ranging from disagree to fully agree [24]. Higher
scores indicate higher levels of fatigue. Findings from recent
studies in patients with multiple sclerosis [28, 29]o rs t r o k e
[30] and people living with HIV/AIDS [31] have shown that
itemsnumber1andnumber2oftheFSSdidnotshowaccep-
table goodness-of-ﬁt and should not be included in the FSS
mean score. Given this ﬁnding, only the last seven of the
original nine (FSS-7) items were included in computing the
mean score, but scores still range from 1 to 7. Conceptually,
the items in FSS-7 refer to fatigue interference with daily
function [30]. Internal consistency of the FSS-7 baseline
scores in the present study was adequate (Cronbach’s alpha
coeﬃcient = 0.86). Mean FSS-7 scores at baseline did not
diﬀer by interviewer or by hospital site.
2.2.2. Sociodemographic Variables. Data on age (years), sex,
and cohabitation (married/living with a partner) were col-
lected from patients’ medical records, while data on the level
of formal education (less than 11 years versus 11 years or
more) were collected from the questionnaire. Those in paid
work or self-employed were categorized as working, while
all others (full-time home-makers and those on disability or
old-age pensioners) were categorized as not working.
Social class was deﬁned as I (high), II (middle), or III
(low) based on the grouping of professions in the interna-
tional Erikson Goldthorpe Portocare social class schema [31,
32]usingtheOccupationClassiﬁcation2000[32].Socialclass
I thus comprised high-level professionals, while Social class
II consisted of midlevel professionals and administrators,
and Social class III contained employees performing routine
manual labour.
2.2.3. Stroke Type and Location. At admission to the hospital,
computerized tomography (CT) scans were taken of all
patients. Stroke type was categorized based on the radiolo-
gist’s description as one of the following four groups: (a)
ischaemic infarct, (b) haemorrhage, (c) chronic cerebral
ischaemia, and (d) negative ﬁndings. If an additional CT
scanwasperformed,themostrecentdescriptionwasusedfor
categorizing the stroke. Stroke location was grouped as left,4 Stroke Research and Treatment
right,orbilateral.IftheCTscanshowedsignsoflesionsfrom
previous undiagnosed strokes, these lesions were included in
the classiﬁcation of stroke.
2.2.4. Stroke-Related Variables
(1) Physical Function and Activities of Daily Living. The level
of physical functioning was self-rated using 10 physical fun-
ctioning items from the Short Form-36 Acute version (SF-
36A)[ 33]. The SF-36A is a questionnaire that measures
physical and mental issues (one-week recall). Higher scores
correspond to better-perceived quality of life. The SF-36 has
demonstrated reliability and validity [33, 34] and has been
suggested as the preferred instrument to measure disability
in stroke patients [35]. Cronbach’s alpha for scores in the
acute phase of the present study was 0.93. The mean score
for physical functioning from the normal population (M =
81.2) [33] was used to categorize patients as either low or
high physical functioning.
Functional ability was assessed with the activities of daily
living personal activities (ADL-P) Barthel Index (BI) [36].
Ten items were scored. The total score can range from 0
(ADL-P dependent) to 20 (ADL-P independent) [37]. The
Norwegian version of the BI has demonstrated validity and
reliability in stroke patients [38]. Cronbach’s alpha for the BI
for the scores in the acute phase was 0.92.
(2) Depressive Symptoms. Depressive symptom severity was
measured by using the Beck Depression Inventory Version
II (BDI-II) [39]. The instrument consists of 21 groups of
four statements by severity of the symptom (0–3), where
the patient is required to select one in each group. The best
possible score is 0. Cronbach’s alpha for the BDI-II in the
acute phase was 0.85. The BDI-II has been found to be
an acceptable screening instrument for depression in stroke
patients [40]. A cut-oﬀ value of 13 was used to categorize
participants in this study as not depressed (BDI ≤ 13) or de-
pressed (classiﬁed as mild, moderate, or severe) [40].
(3) Other Clinical Characteristics. The patient’s weight and
height were measured in the hospital. Body mass index was
calculated as weight in kilograms divided by the square of
the height in meters. The patients’ use of sleep medication
during the last three days in hospital, their past or present
illnesses and medical diagnoses, and the date of hospital ad-
mission were collected from their medical records.
(4) Prestroke Fatigue. Prestroke fatigue was measured retro-
spectively by two items: “did you experience fatigue before
you had your stroke” (yes/no), and if yes, “how long did
you experience fatigue” (less than a week, less than three
months, 3–6 months, and more than six months). Patients
whoreportedfatiguelastinglongerthanthreemonthsbefore
the stroke were deﬁned as having prestroke fatigue.
2.3. Statistical Analysis. Diﬀerences between groups were as-
sessed by chi-square (χ2) for categorical variables or by t-test
for continuous variables. One-way and two-way repeated-
measures analysis of variance (ANOVA) was used to assess
thecourseoffatigueforthewholesample,forthetwogroups
with low or high physical functioning, for groups with and
without depression (BDI-II scores >13 versus those with
BDI-II scores ≤13) and groups with and without prestroke
fatigue lasting more than three months. In the two-way
ANOVA analyses, the statistical model controlled for level
of physical functioning (continuous variable), for depressive
symptoms (continuous variable), and for prestroke fatigue
(yes/no). For each time point, the fatigue scores were analys-
ed for possible diﬀerences between the groups by a linear
regression controlling for similar covariates as in the two-
way ANOVA analyses. A Rasch measure of the FSS-7 [30]
w a su s e dw h e nF S S - 7s c o r e sw e r et r e a t e da sac o n t i n u o u s
variable;themeanscoresarepresentedin thetextandﬁgures
for ease of interpretation. The level of signiﬁcance was set at
P < 0.05 and all tests were two tailed. The data were analysed
using SPSS for Windows Version 17.0 (SPSS Inc., Ill, USA).
2.4. Ethics. The study was approved by the Regional Medical
Research Ethics Committee of Health East of Norway, the
Norwegian Data Inspectorate, and the hospital units for ap-
proval of security of personal data. Informed written consent
was obtained from all patients.
3. Results
Amongthe95patientsinthesample,56(59%)weremenand
39 (41%) were women. The mean age for the whole cohort
was 67.8 years (standard deviation [SD] = 13.3) and did not
diﬀer signiﬁcantly between men (66.0 years [SD = 12.8]) and
women (70.4 years [13.0], t = 1.64, P = 0.10). Compared
with the women, the men were more likely to have higher
education, be in a paired relationship, and belong to a higher
social class (see Table 1). Clinical characteristics at baseline
are shown in Table 2 for the 95 participants who completed
all four time points.
A previous report from the baseline data on the entire
sample[6]showedthat,exceptforahigherproportionofcir-
culatory diseases and higher proportion of cases with severe
fatigue among women, there were no diﬀerences in clinical
proﬁles between men and women. The level of physical
functioning at baseline ranged from 0 to 100, and 34.7%
(n=3 3 ) had high physical functioning. The depression
scores ranged from 0 to 22 and 26 participants (27.4%) were
depressed. Twenty-six of the patients (27.4%) retrospectively
reported that they had prestroke fatigue lasting more than
three months.
3.1. The Course of Fatigue. The mean FSS-7 scores by sex for
the diﬀerent time points are shown in Figure 1. The within-
subject analysis showed that the patient’s level of fatigue did
not vary over time (Wilks’ lambda = 0.99, F [3,87] = 0.38,
P=0.77), and the slope did not diﬀer by sex (F [1,89] =
0.01, P = 0.96, partial η2 = 0.04) after adjusting for
level of physical functioning and prestroke fatigue. No sex
diﬀerence in fatigue scores was found when separate analysesStroke Research and Treatment 5
Table 1: Sociodemographic characteristics of the sample at baseline.
Sociodemographic variables Total sample
N=9 5
Men
n=5 6
Women
n=3 9
Statistics P
Age, years, mean (SD) 67.8 (13.0) 66.0 (12.79) 70.41 (13.0) t = 1.64 0.10
N (%) n (%) n (%) χ2
Level of formal education 4.78 0.04
<11 years 69 (72.6) 36 (86.4) 33 (84.6)
≥11 years 26 (27.4) 20 (35.7) 6 (15.4)
In paired relationship (yes) 65 (68.4) 43 (76.8) 22 (56.4) 4.42 0.05
Work status 1.88 0.23
Working 24 (25.3) 17 (30.4) 7 (17.9)
Not working 71 (74.7) 39 (69.6) 32 (62.1)
Social class (n = 91) 17.42 0.97
High (class I) 17 (18.7) 13 (24.1) 4 (10.8) <0.001
Middle (class II) 13 (14.3) 1 (1.9) 12 (32.4)
Low (class III) 61 (67.0) 40 (74.1) 21 (56.8)
Table 2:Clinicalcharacteristicsatbaselineofthestudysample(N=
95).
Clinical variables Mean (SD)
SF-36—Physical function (1–100) 61.8 (31.5)
ADL-P (Barthel Index) (1–20) (n = 87) 17.9 (3.9)
Depression (BDI-II sum score) (n = 94) 9.4 (7.4)
Body mass index (n = 85) 26.5 (5.2)
Stroke characteristics n (%)
Stroke type
Infarct 74 (77.9)
Haemorrhage 7 (7.4)
Unknown 14 (14.7)
Location (n=7 2 )
Right 32 (33.7)
Left 26 (27.4)
Bilateral 14 (14.7)
Comorbidity (past or present)
Prestroke fatigue 26 (27.4)
Endocrine 21 (22.1)
Circulatory 55 (57.9)
Respiratory 12 (12.6)
Digestive 9 (9.5)
Muscular 18 (18.9)
Other disease 38 (40.0)
of fatigue scores for each time point was assessed in separate
multivariate linear regression analyses.
Thecourseoffatigueamongpatientswithlowversushigh
scores on depressive symptoms is shown in Figure 2.T h e r e
was no within-subject change over time (Wilks’ lambda =
0.98, F [3,88] = 0.58, P=0.63). However, the pa-tients
without depression showed less fatigue than those with
symptoms of depression (F [1,88] = 3.81, P = 0.05, partial
η2 = 0.04) after adjusting for level of physical functioning
and prestroke fatigue.
When fatigue was assessed in groups with and without
depressionbymultivariatelinearregressionanalysis,patients
without depression reported less fatigue only at the six-
month time point (β = 0.19, P = 0.05) compared with the
acute phase (β = 0.16, P = 0.08). Results showed a similar
trend at 12 months (β = 0.15, P = 0.15), but at 18 months
there was no diﬀerence between the groups (β = 0.05, P =
0.65).
When the course of fatigue was compared between pa-
tients with low and high levels of physical functioning, there
was no within-subject change in fatigue over time (Wilks’
lambda = 0.94, F [3,88] = 1.91, P=0.13), as shown in
Figure 3. However, there was a signiﬁcant between-group
diﬀerence (F [1,88] = 10.46, P = 0.002, partial η2 = 0.10)
after controlling for depressive symptoms and prestroke fati-
gue. The scores diﬀered signiﬁcantly in the acute phase (β =
0.39, P < 0.001), at six-month (β = 0.21, P = 0.04) and 18-
month (β = 0.22, P = 0.04) follow-up, but not at 12 month
follow-up (β = 0.11, P = 0.30).
Meanscoresforthecourseoffatigueamongpatientswith
and without prestroke fatigue are shown in Figure 4. Again,
fatigue did not show any overall within-subject change over
time (Wilks’ lambda = 0.92, F [3,88] = 0.62, P=0.60).
However, the main eﬀect for the between-group comparison
was signiﬁcant, F (1,90) = 10.54, P = 0.002, partial η2 =
0.105. The fatigue scores diﬀered in the acute phase (β =
0.27, P = 0.01), and at six months (β = 0.20, P = 0.05) and at
18 months (β = 0.29, P = 0.008), but was not signiﬁcant at
12 months (β = 0.16, P = 0.11).
4. Discussion
To our knowledge, this is among the ﬁrst studies describing
the course of fatigue in patients with ﬁrst-ever stroke. Longi-
tudinal studies on poststroke fatigue have mainly reported
the prevalence of poststroke fatigue at diﬀerent time points
[13, 41], and ﬁndings from previous studies are contra-
dictory. While an increase in prevalence of fatigue during6 Stroke Research and Treatment
the 18 months after a stroke has been reported [13], other
studies ﬁnd a lower prevalence [41]. A recently published
longitudinal study [42] showed that the proportion of
patients with fatigue in the acute poststroke phase (35%,
n = 38) was similar to the proportion of patients with
fatigue 1.5 years later (33%, n = 36).
The important new ﬁnding from our study is that
patients report diﬀerent trajectories of fatigue depending
on their experience of prestroke fatigue and their level of
physical functioning in the acute phase. These two clinical
factors independently predicted the long-term course of
fatigue in our sample.
The relationship between prestroke fatigue and post-
stroke fatigue has previously been reported in cross-sectional
studies [5, 6]. However, a new ﬁnding from our study is that
patients who reported prestroke fatigue showed a relatively
high level of fatigue over time in the poststroke period, while
patients with no history of prestroke fatigue showed a stable
course of relatively low fatigue over time. When studying
poststroke fatigue, it is important to take into consideration
that the prevalence of fatigue in the general population is
relatively high, and that fatigue measured in the early period
after a stroke may not necessarily be caused by the stroke.
Studies of the general population have found prevalence
rates of current severe fatigue ranging from 14% to 38%
[3, 43, 44]. A prevalence of 23% severe fatigue for the
general population in Norway was reported using the same
instrument (FSS reported) [4].
When the course of fatigue among patients with or
without depression was assessed in our study, the diﬀerences
in fatigue levels observed at the acute phase and at six-month
follow-up were not evident 12 months after stroke. Another
study [17] showed that depressive symptoms had a tendency
to predict fatigue at one year after stroke. However, in that
study, depressive symptoms were only borderline signiﬁcant
as a predictor (P = 0.07). Direct comparison between these
studies is complicated because one of the studies included
patients with recurrent stroke [42], while the other study
had patients from a rehabilitation clinic [13] where the
patients might have more impairment. Although several
studies have shown that depression is related to high levels
of fatigue [10, 13–15, 23], this association does not seem
to be evident from a longitudinal perspective. Diﬀerence in
fatiguelevelsintheacutephasebetweenpatientswithno/low
depression versus those with mild/high depression seems
to disappear during the period between the acute phase
and 18-month follow-up, although the diﬀerence in fatigue
between patients with and without depression remains at
six months after stroke. This would support Kirkevold’s
proposal [45] that the recovery from stroke occurs in three
phases: stabilization, adjusting for the long-term eﬀects of
the stroke, and getting on with life. It is possible that both
fatigue and depression are common responses to the experi-
encesoftheacutephaseofstroke,withapositiverelationship
between them, while poststroke experience in the later stages
may have an independent eﬀect on fatigue and depression
with no observable relationship.
In the acute phase, we found a higher proportion of
women than men with severe fatigue [6], but no signiﬁcant
diﬀerencesbetweensexes inmeanfatigue.Thisstudy showed
that mean fatigue did not diﬀer over time in relation to
sex. Similar ﬁndings are reported in most other studies of
poststroke fatigue [5, 15–18, 46]. However, other studies
[11, 12] have shown that vitality is inversely associated with
fatigue.Becausefemalestrokepatientsreportedlowervitality
than men, it is possible that the observed eﬀect of sex
on fatigue may need to be examined further in terms of
vitality.Furtherstudyoftherelationshipbetweenfatigueand
vitality is needed in order to interpret the sex diﬀerences in
fatigue and vitality and to clarify the concepts of fatigue and
vitality.
Ourﬁndingsindicatethatpoststrokefatiguehasdiﬀerent
trajectories over time, depending on the patient’s level of
physical functioning, level of depressive symptoms, and par-
ticularly his/her history of chronic fatigue prior to the stroke.
In studies exploring the aetiology and possible antecedents
of poststroke fatigue, these factors need to be considered. For
example, the aetiology of chronic fatigue might be diﬀerent
from fatigue that develops after stroke, and would require a
diﬀerent intervention approach. Fatigue needs to be studied
more intensely in homogeneous groups during poststroke
recovery.
Strengths of this study include the low attrition over
18 months and perhaps because of the large number of
participants who were interviewed, there were no missing
responses on any of the questionnaire items. One limitation
with the study is that prestroke fatigue was measured retro-
spectively. Furthermore, the sample was recruited from only
two hospitals in Norway. Although only patients with ﬁrst-
ever clinical presentation of stroke were included in the
sample, and none of the participants had a history of clinical
stroke, the CT ﬁndings showed that nine had signs of pre-
vious stroke. People who are interviewed face to face may
have a tendency to give more socially acceptable responses
than those who respond by means of a questionnaire [47].
A possible consequence of this may be under-reporting of
depressive symptoms among those who were interviewed.
However, at baseline, fatigue scores did not diﬀer by inter-
viewer.
A systematic review of empirical studies of poststroke
fatigue [9] concluded that the fatigue experience should
be conceptualized and studied as a multidimensional phe-
nomenon including fatigue intensity, quality, timing, ﬂuc-
tuation, and long-term trajectory. In this study, fatigue was
measured using the FSS-7 [30], an abbreviated version of the
FSSscale[24].AsmentionedbyDittneretal.[48]andothers,
FSS is predominantly a measure of fatigue interference with
daytime function. Thus, other dimensions of fatigue, such as
severityorfrequency,mayhaveadiﬀerenttrajectorythanthe
fatigue described in this study.
5. Conclusion
Because patients with and without prestroke fatigue experi-
ence a diﬀerent but stable trajectory of poststroke fatigue,
future studies need to control for prestroke fatigue experi-
ence to develop knowledge about the aetiology of poststrokeStroke Research and Treatment 7
fatigue. Intervention studies should either control for pre-
stroke fatigue experience or consider excluding patients with
prestroke fatigue when studying the eﬀect of interventions
for poststroke fatigue. A more critical approach would be
to partition out, both conceptually and in measurement, the
components of fatigue that are generic and the components
that are stroke related. It is possible that the presence of
prestrokefatigueexacerbatesthefatigueresponseafterexper-
iencing a stroke.
Acknowledgments
The Research Council of Norway (Grant no. 176503) and
Buskerud University College, Drammen, Norway, funded
this paper. This study is a product stemming from the Re-
search Project: Poststroke Fatigue for which Dr. Hesook Suzie
Kim is the project director and Drs. Grethe Eilertsen, Anners
Lerdal, and Heidi Ormstad are the principal researchers.
This paper was funded by the Research Council of Norway
and Buskerud University College from 2006 to 2010. The
authors acknowledge the support and assistance provid-
ed by research assistant Gunn Pedersen and various staﬀ
members of Buskerud Hospital Trust in Drammen and Oslo
University Hospital, Aker in Oslo, Norway, in carrying out
this research project. AL has received funding from the
RCN (Leif Eriksson Scholarship Grant number 19256), the
Norwegian Nurses Organization and the U.S., Norway Fulb-
right Foundation.
References
[1] F. Staub and J. Bogousslavsky, “Fatigue after stroke: a major
but neglected issue,” Cerebrovascular Diseases,v o l .1 2 ,n o .2 ,
pp. 75–81, 2001.
[2] W. Morley, K. Jackson, and G. E. Mead, “Post-stroke fatigue:
an important yet neglected symptom,”Age and Ageing, vol. 34,
no. 3, p. 313, 2005.
[3] J. H. Loge, Ø. Ekeberg, and S. Kaasa, “Fatigue in the general
Norwegian population: normative data and associations,”
Journal of Psychosomatic Research, vol. 45, no. 1, pp. 53–65,
1998.
[4] A. Lerdal, A. K. Wahl, T. Rustøen, B. R. Hanestad, T. Moum,
and P. Bjerregaard, “Fatigue in the general population: a
translation and test of the psychometric properties of the
Norwegian version of the fatigue severity scale,” Scandinavian
Journal of Public Health, vol. 33, no. 2, pp. 123–130, 2005.
[ 5 ]S .C h o i - K w o n ,S .W .H a n ,S .U .K w o n ,a n dJ .S .K i m ,“ P o s t -
stroke fatigue: characteristics and related factors,” Cerebro-
vascular Diseases, vol. 19, no. 2, pp. 84–90, 2005.
[6] A. Lerdal, L. N. Bakken, E. F. Rasmussen et al., “Physical
impairment, depressive symptoms and pre-stroke fatigue are
relatedtofatigueintheacutephaseafterstroke,”Disabilityand
Rehabilitation, vol. 33, no. 4, pp. 334–342, 2011.
[7] L. B. Krupp, L. A. Alvarez, N. G. LaRocca, and L. C. Schein-
berg, “Fatigue in multiple sclerosis,” Archives of Neurology, vol.
45, no. 4, pp. 435–437, 1988.
[8] A. Lerdal, “A theoretical extension of the concept of energy
through an empirical study,” Scandinavian Journal of Caring
Sciences, vol. 16, no. 2, pp. 197–206, 2002.
[9] A. Lerdal, L. N. Bakken, S. E. Kouwenhoven et al., “Poststroke
fatigue—a review,” Journal of Pain and Symptom Management,
vol. 38, no. 6, pp. 928–949, 2009.
[10] E. L. Glader, B. Stegmayr, and K. Asplund, “Poststroke fatigue:
a 2-year follow-up study of stroke patients in Sweden,” Stroke,
vol. 33, no. 5, pp. 1327–1333, 2002.
[11] N. E. Mayo, L. Poissant, S. Ahmed et al., “Incorporating the
International Classiﬁcation of Functioning, Disability, and
Health (ICF)into anelectronic health record tocreate indicat-
ors of function: proof of concept using the SF-12,” Journal of
theAmericanMedicalInformaticsAssociation,vol.11,no .6,pp .
514–522, 2004.
[12] G.E.Mead,C.Graham,P.Dormanetal.,“Fatigueafterstroke:
baseline predictors and inﬂuence on survival. analysis of data
from UK patients recruited in the international stroke trial,”
PLoS ONE, vol. 6, no. 3, article e16988, 2011.
[13] V. P. Schepers, A. M. Visser-Meily, M. Ketelaar, and E. Linde-
man, “Poststroke fatigue: course and its relation to personal
and stroke-related factors,” Archives of Physical Medicine and
Rehabilitation, vol. 87, no. 2, pp. 184–188, 2006.
[14] S. Choi-Kwon, J. Choi, S. U. Kwon, D. W. Kang, and J.
S. Kim, “Fluoxetine is not eﬀective in the treatment of
poststroke fatigue: a double-blind, placebo-controlled study,”
Cerebrovascular Diseases, vol. 23, no. 2-3, pp. 103–108, 2007.
[15] H. Naess, H. I. Nyland, L. Thomassen, J. Aarseth, and K. M.
Myhr, “Fatigue at long-term follow-up in young adults with
cerebral infarction,” Cerebrovascular Diseases,v o l .2 0 ,n o .4 ,
pp. 245–250, 2005.
[16] J.L.Ingles,G.A.Eskes,andS.J.Phillips,“Fatigueafterstroke,”
Archives of Physical Medicine and Rehabilitation,v o l .8 0 ,n o .2 ,
pp. 173–178, 1999.
[17] P. Appelros, “Prevalence and predictors of pain and fatigue
after stroke: a population-based study,” International Journal
of Rehabilitation Research, vol. 29, no. 4, pp. 329–333, 2006.
[18] G. E. Carlsson, A. M¨ oller, and C. Blomstrand, “Consequences
ofmildstrokeinpersons<75years-A1-yearfollow-up,”Cere-
brovascular Diseases, vol. 16, no. 4, pp. 383–388, 2003.
[19] G. Spalletta, A. Ripa, and C. Caltagirone, “Symptom proﬁle
of DSM-IV major and minor depressive disorders in ﬁrst-ever
stroke patients,” American Journal of Geriatric Psychiatry, vol.
13, no. 2, pp. 108–115, 2005.
[20] World Health Organization, International Classiﬁcation
of Diseases (ICD), Version for 2007, http://apps.who.int/
classiﬁcations/apps/icd/icd10online/.
[21] E. Aberg, G. Adielsson, and A. Almqvist, “Multicenter trial of
hemodilutioninischemicstroke—backgroundandstudypro-
tocol,” Stroke, vol. 16, no. 5, pp. 885–890, 1985.
[22] H. Naess, U. Waje-Andreassen, L. Thomassen, H. Nyland,
and K. M. Myhr, “Health-related quality of life among young
adults with ischemic stroke on long-term follow-up,” Stroke,
vol. 37, no. 5, pp. 1232–1236, 2006.
[23] I. G. L. van de Port, G. Kwakkel, V. P. M. Schepers, C. T.
I. Heinemans, and E. Lindeman, “Is fatigue an independent
factor associated with activities of daily living, instrumental
activities of daily living and health-related quality of life in
chronic stroke?” Cerebrovascular Diseases,v o l .2 3 ,n o .1 ,p p .
40–45, 2007.
[24] L. B. Krupp, N. G. LaRocca, J. Muir-Nash, and A. D. Steinberg,
“The fatigue severity scale. Application to patients with multi-
ple sclerosis and systemic lupus erythematosus,” Archives of
Neurology, vol. 46, no. 10, pp. 1121–1123, 1989.
[ 2 5 ]L .K l e i n m a n ,M .W .Z o d e t ,Z .H a k i me ta l . ,“ P s y c h o m e t r i c
evaluation of the fatigue severity scale for use in chronic
hepatitisC,”Quality ofLife Research,vol. 9,no. 5,pp.499–508,
2000.8 Stroke Research and Treatment
[26] U. Roelcke, L. Kappos, J. Lechner-Scott et al., “Reduced glu-
cosemetabolisminthefrontalcortexandbasalgangliaofmul-
tiple sclerosis patients with fatigue: a 18F-ﬂuorodeoxyglucose
positron emission tomography study,” Neurology, vol. 48, no.
6, pp. 1566–1571, 1997.
[27] L. Whitehead, “The Measurement of Fatigue in Chronic Ill-
ness: a systematic review of unidimensional and multidimen-
sional fatigue measures,” Journal of Pain and Symptom Man-
agement, vol. 37, no. 1, pp. 107–128, 2009.
[28] R. J. Mills, C. A. Young, R. S. Nicholas, J. F. Pallant, and A.
Tennant,“RaschanalysisoftheFatigueSeverityScaleinmulti-
ple sclerosis,” Multiple Sclerosis, vol. 15, no. 1, pp. 81–87, 2009.
[29] A. Lerdal, S. Johansson, A. Kottorp, and L. von Koch, “Psycho-
metric properties of the fatigue severity scale: Rrasch analyses
ofresponsesinaNorwegian andaSwedishMScohort,” Multi-
ple Sclerosis, vol. 16, no. 6, pp. 733–741, 2010.
[30] A.LerdalandA.Kottorp,“PsychometricpropertiesoftheFati-
gue Severity Scale-Rasch analyses of individual responses in
aN o r w e g i a ns t r o k ec o h o r t , ”International Journal of Nursing
Studies, vol. 48, no. 10, pp. 1258–1265, 2011.
[31] L. Thorsen, W. Nystad, H. Stigum et al., “The association
between self-reported physical activity and prevalence of de-
pression and anxiety disorder in long-term survivors of tes-
ticular cancer and men in a general population sample,” Sup-
portive Care in Cancer, vol. 13, no. 8, pp. 637–646, 2005.
[32] S. Krokstad and S. Westin, “Health inequalities by socioeco-
nomicstatusamongmenintheNord-TrøndelagHealthStudy,
Norway,” Scandinavian Journal of Public Health, vol. 30, no. 2,
pp. 113–124, 2002.
[33] J. Ware, K. K. Snow, and M. Kosinski, SF-36 Health Survey:
Manual and Interpretation Guide, Quality Metric Incorpo-
rated, Lincon, RI, USA, 2002.
[34] J.H.Loge,S.Kaasa,M.J.Hjermstad,andT.K.Kvien,“Transla-
tion and performance of the Norwegian SF-36 Health Survey
in patients with rheumatoid arthritis. I. Data quality, scaling
assumptions, reliability, and construct validity,” Journal of Cli-
nical Epidemiology, vol. 51, no. 11, pp. 1069–1076, 1998.
[35] C. Weimar, T. Kurth, K. Kraywinkel et al., “Assessment of fun-
ctioning and disability after ischemic stroke,” Stroke, vol. 33,
no. 8, pp. 2053–2059, 2002.
[36] F. I. Mahoney and D. W. Barthel, “Functional evaluation: the
Barthel index,” Maryland State Medical Journal, vol. 14, pp.
61–65, 1965.
[37] D. T. Wade and C. Collin, “The Barthel ADL Index: a standard
measure of physical disability?” International Disability Stud-
ies, vol. 10, no. 2, pp. 64–67, 1988.
[38] K. Laake, P. Laake, A. H. Ranhoﬀ,U .S v e e n ,T .B .W y l l e r ,a n d
E. Bautz-Holter, “The Barthel ADL index: factor structure de-
pends upon the category of patient,” Age and Ageing, vol. 24,
no. 5, pp. 393–397, 1995.
[39] A. T. Beck, R. A. Steer, and G. K. Brown, BDI–II, Beck De-
pression Inventory Manual, Psychological Corporation, San
Antonio, Tex, USA, 2nd edition, 1996.
[ 4 0 ]I .A b e n ,F .V e r h e y ,R .L o u s b e r g ,J .L o d d e r ,a n dA .H o n i g ,
“Validity of the Beck depression inventory, hospital anxiety
and depression scale, SCL-90, and hamilton depression rating
scale as screening instruments for depression in stroke pa-
tients,” Psychosomatics, vol. 43, no. 5, pp. 386–393, 2002.
[41] D. Christensen, S. P. Johnsen, T. Watt, I. Harder, M. Kirkevold,
and G. Andersen, “Dimensions of post-stroke fatigue: a two-
year follow-up study,” Cerebrovascular Diseases, vol. 26, no. 2,
pp. 134–141, 2008.
[42] L. Snaphaan, S. van der Werf, and F. -E. de Leeuw, “Time
course and risk factors of post-stroke fatigue: a prospective
cohort study,” European Journal of Neurology, vol. 18, no. 4,
pp. 611–617, 2011.
[43] T. Pawlikowska, T. Chalder, S. R. Hirsch, P. Wallace, D. J. M.
Wright, and S. C. Wesely, “Population based study of fatigue
and psychological distress,” British Medical Journal, vol. 308,
no. 6931, pp. 763–766, 1994.
[44] M. K. Chen, “The epidemiology of self-perceived fatigue
among adults,” Preventive Medicine, vol. 15, no. 1, pp. 74–81,
1986.
[45] M.Kirkevold,“Theunfoldingillnesstrajectoryofstroke,”Dis-
ability and Rehabilitation, vol. 24, no. 17, pp. 887–898, 2002.
[46] J.Lynch,G.Mead,C.Greig,A.Young,S.Lewis,andM.Sharpe,
“Fatigueafterstroke:thedevelopmentandevaluationofacase
deﬁnition,” Journal of Psychosomatic Research, vol. 63, no. 5,
pp. 539–544, 2007.
[47] T. Moum, “Mode of administration and interviewer eﬀects
in self-reported symptoms of anxiety and depression,” Social
Indicators Research, vol. 45, no. 1–3, pp. 279–318, 1998.
[48] A. J. Dittner, S. C. Wessely, and R. G. Brown, “The assessment
of fatigue: a practical guide for clinicians and researchers,”
Journal of Psychosomatic Research, vol. 56, no. 2, pp. 157–170,
2004.